Report Critical of CERN Fails to Identify Savings

LONDON—An international review of the European Organization for Nuclear Research (CERN) in Geneva has dealt a double blow to the laboratory's administration. Severely critical of CERN's management, accounting and personnel policies, it nevertheless has not identified cash savings that would persuade Britain to remain a member of Europe's premier high-energy physics center. The review panel, set up at Britain's instigation, presented its interim findings to CERN's council in early June. It

Written byJon Turney
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The review panel, set up at Britain's instigation, presented its interim findings to CERN's council in early June. Its most urgent recommendation is to freeze long-term appointments and shrink the 3,500-member staff by 500 in the next two years. Unless CERN takes this step, the group's unpublished interim report said, "it is doomed to paralysis of an all-too-familiar kind" by a static and aging workforce.

But paying off departing staff members would cost extra money in the short term, and Britain's motive in demanding the review was to find budget savings. An earlier British review of the nation's contribution to particle physics recommended that the country spend no more than £30 million ($48 million) at CERN each year. That figure was repeated in this year's spending advice to the government from the Advisory Board for the Research Councils (ABRC). The board then said further action should be delayed pending the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery